Non-tuberculous Mycobacteria (NTM) are a heterogeneous group of organisms that have been increasingly reported in North America 1, 2 and recognized to be a pulmonary pathogen in non immunocompromised persons, in middle age-elderly people, non smoking women, apart from the high risk population with underlying lung disease, and also in Cystic fibrosis (CF) population.